NIH to start ‘flurry’ of large studies of potential Covid-19 treatments
The National Institutes of Health is preparing to launch a “flurry” of large clinical trials to test new approaches to treating Covid-19, according to the agency’s director, hoping to expand what for now remains a limited arsenal of therapies to help people with the disease.
In an interview, NIH Director Francis Collins characterized the studies as “really well-powered, rigorously designed clinical trials.”
Read Original Article: NIH to start ‘flurry’ of large studies of potential Covid-19 treatments »
